Homo sapiens Protein: ALK | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||
InnateDB Protein | IDBP-42088.6 | ||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||
Gene Symbol | ALK | ||||||||||||||||||||||||||
Protein Name | anaplastic lymphoma receptor tyrosine kinase | ||||||||||||||||||||||||||
Synonyms | CD246; NBLST3; | ||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||
Ensembl Protein | ENSP00000373700 | ||||||||||||||||||||||||||
InnateDB Gene | IDBG-42084 (ALK) | ||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||
Function | Neuronal orphan receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system. Transduces signals from ligands at the cell surface, through specific activation of the mitogen-activated protein kinase (MAPK) pathway. Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif. Following activation by ligand, ALK induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Acts as a receptor for ligands pleiotrophin (PTN), a secreted growth factor, and midkine (MDK), a PTN-related factor, thus participating in PTN and MDK signal transduction. PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation. MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction. Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase. Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK. {ECO:0000269PubMed:11121404, ECO:0000269PubMed:11278720, ECO:0000269PubMed:11387242, ECO:0000269PubMed:11809760, ECO:0000269PubMed:12107166, ECO:0000269PubMed:12122009, ECO:0000269PubMed:15226403, ECO:0000269PubMed:15908427, ECO:0000269PubMed:16317043, ECO:0000269PubMed:16878150, ECO:0000269PubMed:17274988}. | ||||||||||||||||||||||||||
Subcellular Localization | Cell membrane {ECO:0000269PubMed:16317043, ECO:0000269PubMed:9174053}; Single-pass type I membrane protein {ECO:0000269PubMed:16317043, ECO:0000269PubMed:9174053}. Note=Membrane attachment was crucial for promotion of neuron-like differentiation and cell proliferation arrest through specific activation of the MAP kinase pathway. | ||||||||||||||||||||||||||
Disease Associations | Note=A chromosomal aberration involving ALK is found in a form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with NPM1. The resulting chimeric NPM1-ALK protein homodimerize and the kinase becomes constitutively activated. The constitutively active fusion proteins are responsible for 5-10% of non-Hodgkin lymphomas.Note=A chromosomal aberration involving ALK is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;11)(p23;p15) with CARS; translocation t(2;4)(p23;q21) with SEC31A.Note=A chromosomal aberration involving ALK is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALO17.Neuroblastoma 3 (NBLST3) [MIM:613014]: A common neoplasm of early childhood arising from embryonic cells that form the primitive neural crest and give rise to the adrenal medulla and the sympathetic nervous system. {ECO:0000269PubMed:18724359, ECO:0000269PubMed:18923523, ECO:0000269PubMed:18923525}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.Note=The ALK signaling pathway plays an important role in glioblastoma, the most common malignant brain tumor of adults and one of the most lethal cancers. It regulates both glioblastoma migration and growth. | ||||||||||||||||||||||||||
Tissue Specificity | Expressed in brain and CNS. Also expressed in the small intestine and testis, but not in normal lymphoid cells. {ECO:0000269PubMed:9174053}. | ||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 58 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||
InterPro |
IPR000719
Protein kinase domain IPR000998 MAM domain IPR001245 Serine-threonine/tyrosine-protein kinase catalytic domain IPR002172 Low-density lipoprotein (LDL) receptor class A repeat IPR002290 Serine/threonine/dual specificity protein kinase, catalytic domain IPR008985 Concanavalin A-like lectin/glucanases superfamily IPR011009 Protein kinase-like domain IPR020635 Tyrosine-protein kinase, catalytic domain |
||||||||||||||||||||||||||
PFAM |
PF00069
PF00629 PF07714 PF00057 |
||||||||||||||||||||||||||
PRINTS |
PR00020
PR00109 PR00261 |
||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||
SMART |
SM00137
SM00192 SM00220 SM00219 |
||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||
SwissProt | Q9UM73 | ||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q9UM73 | ||||||||||||||||||||||||||
TrEMBL | Q580I3 | ||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||
Entrez Gene | 238 | ||||||||||||||||||||||||||
UniGene | Hs.654469 | ||||||||||||||||||||||||||
RefSeq | NP_004295 | ||||||||||||||||||||||||||
HUGO | HGNC:427 | ||||||||||||||||||||||||||
OMIM | 105590 | ||||||||||||||||||||||||||
CCDS | CCDS33172 | ||||||||||||||||||||||||||
HPRD | 00104 | ||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||
EMBL | AB209477 AC074096 AC093756 AC098874 AC106870 U62540 U66559 | ||||||||||||||||||||||||||
GenPept | AAB71619 AAC51104 AAX76514 AAX88892 AAX93126 AAY15027 BAD92714 | ||||||||||||||||||||||||||